Evonik

Activities: Ingredients

Trending Articles

  1. Sanofi opens €558m modular vaccine and biologics manufacturing facility in Singapore The biopharmaceutical manufacturing facility will allow Sanofi to manufacture up to four vaccines and biologic medicines simultaneously, while also enhancing the area's...
  2. Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
  3. Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The new fight against diabetes and obesity Incretin mimetics administered by autoinjectors or pens enable significant weight reduction and offer an important way to combat obesity and prevent type 2 diabetes. As such,...
  5. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Manufacturing

Evonik launches Eudracap colon functional capsules

Eudracap colon targets the ileo-colonic region with functional, ready-to-fill capsules
Drug Delivery

Evonik begins construction on pharmaceutical lipids facility

The centre will be built on the grounds of Evonik Tippecanoe Laboratories and scheduled to go "onstream" in 2025
Infection Control

Evonik launches plant-based squalene to boost vaccine efficacy

It meets the demand for a secure commercial supply of non-animal-derived squalene
Packaging

Evonik wins CPHI Excellence award for "Packaging and Drug Delivery"

The award was presented at the CPHI pharmaceutical trade show in Frankfurt on November 1, 2022
Finance

Evonik introduces three product lines for health care business

This structural shift is aimed to further transitions the health care business line into a system solutions partner for the pharmaceutical and biotech industries
Manufacturing

Evonik invests in 3D printed tablet tech for controlled delivery

Laxxon Medical’s 3D screen printing technology allows tablets to be constructed in layers of API or inert ingredients
Manufacturing

Evonik increases plant-derived cholesterol supply

The ingredient is used in the manufacture of mRNA vaccines and gene therapies
Subscribe now